State AZ
Clinical Trials in Arizona
Recruiting clinical trials with at least one study location in Arizona. Data updated daily from ClinicalTrials.gov.
Top Conditions in Arizona
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
NCT06395519 Phase 1, Phase 2
Recruiting
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Condition
Advanced or Metastatic Solid Tumors
Enrollment
120 pts
Location
United States
Sponsor
858 Therapeutics, Inc.
NCT05966194 Phase 2
Recruiting
RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radia...
Condition
Oral Mucositis
Enrollment
216 pts
Location
United States
Sponsor
EpicentRx, Inc.
NCT06568692 Phase 2
Recruiting
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metast...
Condition
Breast Cancer
Enrollment
90 pts
Location
United States
Sponsor
Processa Pharmaceuticals
NCT06621251 Phase 2
Recruiting
Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosth...
Condition
Prosthetic Joint Infections of Hip
Enrollment
60 pts
Location
United States
Sponsor
Trellis Bioscience LLC
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT06251310 Phase 1
Recruiting
SW-682 in Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
186 pts
Location
United States
Sponsor
SpringWorks Therapeutics, Inc.
NCT06662786 Phase 3
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or ...
Condition
Colorectal Neoplasms
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Janssen Research & Development
NCT07110454 N/A
Recruiting
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
Condition
Epilepsy
Enrollment
210 pts
Location
United States
Sponsor
Epiminder America, Inc.
NCT05283720 Phase 2
Recruiting
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneou...
Condition
Non-Hodgkin Lymphoma
Enrollment
496 pts
Location
United States, China, Czechia
Sponsor
Genmab
NCT03547973 Phase 2
Recruiting
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Canno...
Condition
Metastatic Urothelial Cancer
Enrollment
827 pts
Location
United States, France, Germany
Sponsor
Gilead Sciences
NCT04390737 Phase 1, Phase 2
Recruiting
Evaluate the Safety and Clinical Activity of HH2853
Condition
FL Lymphoma
Enrollment
254 pts
Location
United States, China
Sponsor
Haihe Biopharma Co., Ltd.
NCT04989803 Phase 1, Phase 2
Recruiting
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-...
Condition
Relapsed and/or Refractory B-cell Lymphoma
Enrollment
247 pts
Location
United States, Australia, Germany
Sponsor
Kite, A Gilead Company
NCT06252753 N/A
Recruiting
Observational Study Protocol: LIVER-R
Condition
Hepatobiliary Cancers
Enrollment
4,490 pts
Location
United States, Australia, Austria
Sponsor
AstraZeneca
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06321796 Phase 2
Recruiting
Microbiota Transfer Therapy for Children and Adults With Both Pitt Hopkins Syndr...
Condition
Pitt Hopkins Syndrome
Enrollment
20 pts
Location
United States
Sponsor
Gut-Brain-Axis Therapeutics In
NCT06813820 N/A
Recruiting
RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial
Condition
Left Ventricle Remodeling
Enrollment
135 pts
Location
United States
Sponsor
BioVentrix
NCT07089888 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Condition
Tophaceous Gout
Enrollment
250 pts
Location
United States
Sponsor
Crystalys Therapeutics
NCT05354141 Phase 3
Recruiting
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (...
Condition
Acute Respiratory Distress Syndrome
Enrollment
970 pts
Location
United States
Sponsor
Direct Biologics, LLC
NCT02555280 N/A
Recruiting
Coflex PS3 Actual Conditions for Use Study
Condition
Spinal Stenosis Lumbar
Enrollment
300 pts
Location
United States
Sponsor
Xtant Medical
NCT05243797 Phase 3
Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Al...
Condition
Multiple Myeloma
Enrollment
1,594 pts
Location
United States, Argentina, Australia
Sponsor
European Myeloma Network B.V.
NCT05040360 Phase 2
Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendo...
Condition
Metastatic Malignant Neoplasm in the Liver
Enrollment
141 pts
Location
United States, Mexico, Uruguay
Sponsor
SWOG Cancer Research Network
NCT06079879 Phase 3
Recruiting
A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BA...
Condition
Essential Thrombocythemia
Enrollment
340 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05659524 N/A
Recruiting
Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery
Condition
Pituitary Tumor
Enrollment
140 pts
Location
United States
Sponsor
Lori Wood
NCT05743699 N/A
Recruiting
Adaptation and Evaluation of Bright Horizons
Condition
Alcohol Abuse
Enrollment
100 pts
Location
United States
Sponsor
Johns Hopkins Bloomberg School